IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,299 | -5.5% | 614 | +1.7% | 0.00% | – |
| Q2 2023 | $28,895 | +21.5% | 604 | +0.2% | 0.00% | – |
| Q1 2023 | $23,777 | -22.0% | 603 | -44.0% | 0.00% | – |
| Q4 2022 | $30,481 | -17.6% | 1,077 | -9.3% | 0.00% | – |
| Q3 2022 | $37,000 | -7.5% | 1,187 | +1.7% | 0.00% | – |
| Q2 2022 | $40,000 | -59.2% | 1,167 | -46.1% | 0.00% | – |
| Q1 2022 | $98,000 | +78.2% | 2,167 | +82.3% | 0.00% | – |
| Q4 2021 | $55,000 | +587.5% | 1,189 | +397.5% | 0.00% | – |
| Q3 2021 | $8,000 | +700.0% | 239 | +1157.9% | 0.00% | – |
| Q2 2021 | $1,000 | – | 19 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 19 | -62.0% | 0.00% | – |
| Q3 2020 | $1,000 | -92.3% | 50 | -91.7% | 0.00% | – |
| Q1 2020 | $13,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |